Heart club receives hundreds of pounds from donations
Bournemouth Heart Club recently received a £400 donation from Bournemouth Rotary Club.
This is nothing new for Bournemouth Rotary, with their longstanding commitment to support 'local health initiatives'.
The president, Virginia Beck, presented the cheque of £400 to Caroline Marshall, the general manager of the heart club.
Founded in 1996, the heart club provides rehabilitation support for individuals recovering from cardiac procedures or living with a high risk of coronary heart disease.
Today, its services also extend to those managing chronic conditions such as type 2 diabetes, offering tailored exercise programmes and health education to improve long-term outcomes.
A spokesperson for Bournemouth Rotary said: "The club's support of the Heart Club spans decades, with former member the late Peter Bath instrumental in funding the construction of the gymnasium in 1996.
"This latest donation reflects Rotary's continued dedication to promoting community well-being."
President Beck stated that Bournemouth Heart Club represents 'the very best of community care'.
She said: "The Bournemouth Heart Club represents the very best of community care - compassionate, consistent, and life-changing.
"We're proud to support its mission and hope this contribution helps sustain its vital work for those recovering from cardiac issues and managing long-term health conditions."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Teenagers aren't good at spotting misinformation online
Misinformation is found in every element of our online lives. It ranges from fake products available to buy, fake lifestyle posts on social media accounts and fake news about health and politics. Misinformation has an impact not only on our beliefs but also our behaviour: for example, it has affected how people vote in elections and whether people intend to have vaccinations. And since anyone can create and share online content, without the kind of verification processes or fact checking typical of more traditional media, misinformation has proliferated. This is particularly important as young people increasingly turn to social media for all kinds of information, using it as a source of news and as a search engine. But despite their frequent use of social media, teenagers struggle to evaluate the accuracy of the content they consume. A 2022 report from media watchdog Ofcom found that only 11% of 11 to 17 year olds could reliably recognise the signs that indicated a post was genuine. My research has explored what teenagers understand about misinformation online. I held focus groups with 37 11- to 14-year-olds, asking them their views on misinformation. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. I found that the young people in the study tended to – wrongly – believe that misinformation was only about world events and scams. Because of this, they believed that they personally did not see a lot of misinformation. '[My Instagram] isn't really like 'this is happening in the world' or whatever, it's just kind of like life,' one said. This may make them vulnerable to misinformation as they are only alert for it in these domains. There was also wide variation in how confident they felt about spotting misinformation. Some were confident in their skills. 'I'm not daft enough to believe it,' as one put it. Others admitted to being easily fooled. This was an interesting finding, as previous research has indicated that most people have a high level of confidence in their personal ability to spot misinformation. Most did not fact-check information by cross-referencing what they read with other news sources. They relied instead on their intuition – 'You just see it, you know' – or looked at what others said in comment sections to spot misinformation. But neither of these strategies is likely to be particularly reliable. Relying on gut instinct typically means using cognitive shortcuts such as 'I trust her, so I can trust her post' or 'the website looks professional, so it is trustworthy'. This makes it easy for people to create believable false information. And a study by Ofcom found that only 22% of adults were able to identify signs of a genuine post. This means that relying on other people to help us tell true from false is not likely to be effective. Interestingly, the teens in this study saw older adults, particularly grandparents, as especially vulnerable to believing false information. On the other hand, they viewed their parents as more skilled at spotting misinformation than they themselves were. '[Parents] see it as fake news, so they don't believe it and they don't need to worry about it,' one said. This was unexpected. We might assume that young people, who are often considered digital natives, would see themselves as more adept than their parents at spotting misinformation. Taking responsibility We discussed whose role it was to challenge misinformation online. The teens were reluctant to challenge it themselves. They thought it would not make a difference if they did, or they feared being victimised online or even offline. Instead, they believed that governments should stop the spread of misinformation 'as they know about what wars are happening'. But older participants thought that if the government took a leading role in stopping the spread of misinformation 'there would be protests', as it would be seen as censorship. They also felt that platforms should take responsibility to stop the spread of misinformation to protect their reputation, so that people don't panic about fake news. In light of these findings, my colleagues and I have created a project that works with young people to create resources to help them develop their skills in spotting misinformation and staying safe online. We work closely with young people to understand what their concerns are, and how they want to learn about these topics. We also partner with organisations such as Police Scotland and Education Scotland to ensure our materials are grounded in real-world challenges and informed by the needs of teachers and other adult professionals as well as young people. This article is republished from The Conversation under a Creative Commons license. Read the original article. Yvonne Skipper has received funding from the ESRC, Education Scotland and British Academy.
Yahoo
an hour ago
- Yahoo
Medics objecting to Sandie Peggie's return warned of culpability, tribunal told
Senior medics who objected to a decision to allow a gender-critical nurse to return to work following a dispute with a transgender doctor were warned they were 'culpable' if patient safety concerns were not correctly reported, a tribunal heard. Sandie Peggie was suspended after she complained about having to share a changing room with transgender medic Dr Beth Upton at Victoria Hospital, Kirkcaldy, Fife, on Christmas Eve 2023. She was placed on special leave after Dr Upton made an allegation of bullying and harassment and cited concerns about 'patient care'. Ms Peggie has lodged a claim against NHS Fife and Dr Upton, citing the Equality Act 2010, including sexual harassment; harassment related to a protected belief; indirect discrimination; and victimisation. The tribunal resumed in Dundee on July 16 after an initial set of hearings in February. On Monday, service manager Charlotte Myles, who made a decision to lift the suspension on March 7, told the tribunal that two senior consultants and two senior nurses 'weren't happy' at her decision to allow Ms Peggie to return to work. Ms Myles said that Dr Kate Searle and Dr Maggie Currer both objected to her decision, while senior nurse managers Esther Davidson and Louise Curran 'similarly expressed' objections, but were not able to give an 'accurate response' regarding alleged patient safety concerns. She said she told Ms Peggie verbally on March 7 and in writing on March 12 that the suspension would be lifted. However, it was later reinstated due to issues with looking after the nurse's dog, and she returned to work around April 12 2024. Ms Myles said that 'usually we don't like to suspend' and she believed there were no patient safety issues, the tribunal heard. However she said that she 'wasn't impressed' by allegations made by senior medics and warned them to comply with correct protocols and policies. Ms Myles said: 'When I explained to staff members they weren't particularly happy with my decision initially.' She said she visited Dr Searle's office to co-ordinate a rota and was met with further objections, but warned the consultant she was 'culpable' if allegations were not reported correctly, the tribunal heard. Ms Myles said: 'Kate Searle expressed unhappiness that we were taking Ms Peggie back into the workplace and made a comment saying there had been patient safety issues, there had been other behaviours towards a doctor. I asked if this had been investigated and reported appropriately, and she said no. 'I said that if these events had happened and they had not been reported, you were culpable.' She added: 'They weren't happy but it was my sole responsibility to review the suspension. My primary concern is to make sure patients are getting seen.' The witness said she did not know 'what the indicators were… to be suspended in the first place' and felt there 'was no risk', the tribunal heard. Ms Myles said: 'I wasn't impressed; if someone wants to raise patient safety concern it should go through correct process and be escalated at the time the incident happened. My stance was: 'If you have not followed correct protocol and policy you are culpable'.' She said that Ms Davidson alleged that a doctor had been subject to a racist slur by Ms Peggie, and branded allegations by Ms Curran that the nurse shared Donald Trump's views on gender 'tittle-tattle', the tribunal heard. Ms Myles said: 'It was very similar, tittle-tattle of being a supporter of Donald Trump and sharing his views on gender. That's somebody's personal view and as long as it doesn't impact on workforce or patients or cause harm, people are entitled to have their private views.' She said she perceived Dr Upton to be 'a female colleague', but said: 'I do believe we should make alterations to support everybody, but how we do it is completely out of my remit.' During re-examination by Jane Russell KC, representing NHS Fife and Dr Upton, the witness was asked about the alleged comments. Ms Myles said: 'I was told Sandie Peggie had called a member of the medical team a P**i but that was not reported formally; when I asked Esther which member of the team it was directed at, it took a while to get a response. I believe the person who was supposed to have had the comment directed at them doesn't recall the comment being directed at them.' Judge Alexander Kemp asked if she had seen a previous risk assessment for suspending Ms Peggie, and the witness said she had not, despite asking for previous documentation prior to March 7. The tribunal continues.
Yahoo
an hour ago
- Yahoo
Hayfever sufferers set to get new drug which will provide ‘a better quality of life'
Hayfever sufferers are set to benefit from a new treatment that will provide long-term relief for their symptoms. It has been recommended as an option on the NHS for people whose hayfever symptoms persist even after taking antihistamines or using nasal sprays, by the National Institute for Health and Care Excellence (Nice). Betula verrucosa, sold under the brand name Itulazax 12 SQ-Bet and made by Alk-Abello, is an under-the-tongue immunotherapy tablet that contains birch pollen extract. The drug trains the immune system to tolerate tree pollen over three years of daily use. Severe tree pollen allergies can cause debilitating symptoms for some people during the spring and summer months, including fatigue, breathing difficulties, inflamed sinuses, itchy, watery eyes, and vision changes. Trials show the tablet can significantly reduce the symptoms of severe hayfever by changing how the body responds to allergens. The immunotherapy works by gradually increasing the body's tolerance to tree pollen through controlled daily exposure to small amounts of pollen. Before being given the tablets, patients will require skin prick or blood tests to confirm an allergy to birch tree pollen. Nice estimates that about 27,000 people in England are expected to benefit from the recommendation. Helen Knight, director of medicines evaluation at Nice, said: 'This treatment will help improve people's quality of life. Trials show the tablet can significantly reduce the symptoms of severe hayfever by changing how the body responds to allergens ((Alamy/PA)) 'Severe tree pollen allergies trap people indoors during beautiful weather and disrupt their work, education and family life. 'The daily tablet offers genuine long-term relief rather than just managing symptoms.' According to Allergy UK, birch pollen allergy is estimated to affect about 25% of hayfever sufferers. Amena Warner, head of clinical services at Allergy UK, said: 'Many people don't realise how awful it is having an itchy, runny nose, sneezing episodes or itchy, irritated eyes in the pollen season. 'We frequently hear from people who avoid time outdoors, keep doors and windows shut, check pollen counts and try and minimise any exposure, which takes a significant toll on their physical and emotional wellbeing. 'Nice's recommendation is so important because it provides a genuine opportunity for people to manage the root cause of their pollen allergy, offering the chance to break free from this burden and enjoy a better quality of life.' Emil Stage Olsen, general manager UK and Republic of Ireland at ALK, added: 'We welcome this positive Nice recommendation, which is another meaningful advancement for the UK allergy community. 'Our focus is now on working closely with the NHS to ensure eligible patients can benefit from this first-in-class immunotherapy.' The NHS in England will provide the treatment within three months of Nice publishing its final guidance. Professor Meghana Pandit, co-medical director at NHS England, welcomed the announcement. She said: 'This innovative treatment, which will soon be rolled out on the NHS, enables patients to build up tolerance to birch tree pollen within their immune system, rather than just treating the symptoms – and we hope this will give many a new lease of life, allowing people to spend time enjoying being outside, without the discomfort allergies can bring.'
